Jansen Disease, also known as Jansen Metaphyseal Chondrodysplasia, is an ultra-rare skeletal disorder affecting fewer than 30 reported cases worldwide 🌍.
It is characterised by abnormal growth plate development, causing distorted bone growth and metabolic disturbances.
The disease is progressive, usually presenting in early childhood 👶, and often requires lifelong supportive care.

🧬 Aetiology

Inheritance Pattern: Autosomal dominant – a single mutated allele is sufficient for disease expression.
Genetic Cause: Mutations in the PTH1R gene (parathyroid hormone/parathyroid hormone–related peptide receptor).
Pathophysiology: Constitutive activation of the PTH/PTHrP receptor ➝ mimics continuous PTH action ➝ causes excessive calcium release from bone and renal phosphate wasting.
Result: Severe disturbances in calcium-phosphate homeostasis ⚖️, abnormal ossification, and growth plate disorganisation.

🩺 Clinical Presentation

Growth Abnormalities: Short-limbed dwarfism, stunted growth, and abnormal bone modelling.
Gait & Limb Deformities: Bowed legs (genu varum), waddling gait, and joint contractures restricting mobility 🚶.
Hands & Fingers: Shortened digits, clubbing-like appearance, clinodactyly (curved fingers).
Craniofacial Features: Prominent upper face, small mandible ➝ distinctive facies.
Other Symptoms: Bone pain, fatigue, recurrent kidney stones due to hypercalciuria.

🧪 Investigations

Biochemistry:
- Marked hypercalcaemia 🧪
- Hypophosphataemia (renal phosphate wasting)
- Hypercalciuria ➝ nephrocalcinosis or renal stones possible
PTH Levels: Normal or suppressed, despite hypercalcaemia ➝ key clue distinguishing it from primary hyperparathyroidism.
Radiology: X-rays show widened, irregular metaphyses of long bones, often confused with rickets.

🛠️ Management

No definitive cure – management is supportive and multidisciplinary.
Orthopaedics: Corrective surgery for severe deformities, bracing, and physiotherapy.
Metabolic Monitoring: Control of hypercalcaemia (hydration, bisphosphonates in some cases).
Nephrology: Surveillance for renal complications (stones, nephrocalcinosis).
Rehabilitation: Physical therapy and adaptive devices to maximise independence.
Research: Future therapies may target the PTH1R pathway 🔬.

📊 Key Differentials

Rickets (nutritional or renal)
Other metaphyseal chondrodysplasias
Hyperparathyroidism

📚 References

The Jansen Foundation – Patient support, x-rays, and case studies.
Schipani et al. 2007 – Review of Jansen’s metaphyseal chondrodysplasia.

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Jansen Disease

🦴 About